

Symes R, Whitaker HJ, Ahmad S, et al. Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospital admission among adults aged 75–79 years in England: a multicentre, test-negative, case–control study. Lancet Infect Dis 2025; published online Oct 27. https://doi.org/10.1016/S1473-3099(25)00546-8—In this Article in figure 1, “227 not admitted” should have read “227 excluded”. This correction has been made to the online version as of Nov 6, 2025, and will be made to the printed version.
Infectious Diseases
|15th Jan, 2026
|The Lancet
Infectious Diseases
|15th Jan, 2026
|The Lancet
Infectious Diseases
|15th Jan, 2026
|The Lancet
Infectious Diseases
|15th Jan, 2026
|The Lancet
Infectious Diseases
|15th Jan, 2026
|The Lancet
Infectious Diseases
|15th Jan, 2026
|The Lancet
Infectious Diseases
|15th Jan, 2026
|The Lancet